Cargando…
Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?
Postpartum depression is considered to be a subtype of major depressive disorder that occurs in approximately 10–20% of mothers worldwide. However, in actuality, these numbers are likely underreported due to minimization and the stigma of mental illness. Until recently, there were no approved medica...
Autores principales: | Faden, Justin, Citrome, Leslie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656877/ https://www.ncbi.nlm.nih.gov/pubmed/33224470 http://dx.doi.org/10.1177/2045125320968658 |
Ejemplares similares
-
Brexanolone: panacea for postpartum depression? Reply to: ‘Intravenous brexanolone for postpartum depression: what it is, how well does it work, and will it be used?’
por: Shukla, Ajay Kumar, et al.
Publicado: (2021) -
Efficacy of brexanolone in postpartum depression
por: Rodríguez Mercado, C. M.
Publicado: (2023) -
Treating Postpartum Depression: What Do We Know about Brexanolone?
por: Ali, Muneeza, et al.
Publicado: (2021) -
Safety of Brexanolone in Adults with Postpartum Depression: Postmarketing Surveillance Data
por: Garafola, Svetlana, et al.
Publicado: (2023) -
Open‐label, proof‐of‐concept study of brexanolone in the treatment of severe postpartum depression
por: Kanes, Stephen J., et al.
Publicado: (2017)